BACKGROUND: Whether the method of local anesthetic administration for continuous femoral nerve blocks--basal infusion versus repeated hourly bolus doses--influences block effects remains unknown. METHODS:Bilateral femoral perineural catheters were inserted in volunteers (n = 11). Ropivacaine 0.1% was concurrently administered through both catheters: a 6-h continuous 5 ml/h basal infusion on one side and 6 hourly bolus doses on the contralateral side. The primary endpoint was the maximum voluntary isometric contraction (MVIC) of the quadriceps femoris muscle at hour 6. Secondary endpoints included quadriceps MVIC at other time points, hip adductor MVIC, and cutaneous sensation 2 cm medial to the distal quadriceps tendon in the 22 h after initiation of local anesthetic administration. RESULTS: Quadriceps MVIC for limbs receiving 0.1% ropivacaine as a basal infusion declined by a mean (SD) of 84% (19) compared with 83% (24) for those receiving 0.1% ropivacaine as repeated bolus doses between baseline and hour 6 (paired t test P = 0.91). Intrasubject comparisons (left vs. right) also reflected a lack of difference: the mean basal-bolus difference in quadriceps MVIC at hour 6 was -1.1% (95% CI -22.0-19.8%). The similarity did not reach the a priori threshold for concluding equivalence, which was the 95% CI decreasing within ± 20%. There were similar minimal differences in the secondary endpoints during local anesthetic administration. CONCLUSIONS: This study did not find evidence to support the hypothesis that varying the method of local anesthetic administration--basal infusion versus repeated bolus doses--influences continuous femoral nerve block effects to a clinically significant degree.
RCT Entities:
BACKGROUND: Whether the method of local anesthetic administration for continuous femoral nerve blocks--basal infusion versus repeated hourly bolus doses--influences block effects remains unknown. METHODS: Bilateral femoral perineural catheters were inserted in volunteers (n = 11). Ropivacaine 0.1% was concurrently administered through both catheters: a 6-h continuous 5 ml/h basal infusion on one side and 6 hourly bolus doses on the contralateral side. The primary endpoint was the maximum voluntary isometric contraction (MVIC) of the quadriceps femoris muscle at hour 6. Secondary endpoints included quadriceps MVIC at other time points, hip adductor MVIC, and cutaneous sensation 2 cm medial to the distal quadriceps tendon in the 22 h after initiation of local anesthetic administration. RESULTS:Quadriceps MVIC for limbs receiving 0.1% ropivacaine as a basal infusion declined by a mean (SD) of 84% (19) compared with 83% (24) for those receiving 0.1% ropivacaine as repeated bolus doses between baseline and hour 6 (paired t test P = 0.91). Intrasubject comparisons (left vs. right) also reflected a lack of difference: the mean basal-bolus difference in quadriceps MVIC at hour 6 was -1.1% (95% CI -22.0-19.8%). The similarity did not reach the a priori threshold for concluding equivalence, which was the 95% CI decreasing within ± 20%. There were similar minimal differences in the secondary endpoints during local anesthetic administration. CONCLUSIONS: This study did not find evidence to support the hypothesis that varying the method of local anesthetic administration--basal infusion versus repeated bolus doses--influences continuous femoral nerve block effects to a clinically significant degree.
Authors: Francis V Salinas; Joseph M Neal; Lila A Sueda; Dan J Kopacz; Spencer S Liu Journal: Reg Anesth Pain Med Date: 2004 May-Jun Impact factor: 6.288
Authors: Jean Jacques Eledjam; Philippe Cuvillon; Xavier Capdevila; Philippe Macaire; Sylvain Serri; Elisabeth Gaertner; Denis Jochum Journal: Reg Anesth Pain Med Date: 2002 Nov-Dec Impact factor: 6.288
Authors: Maria Bauer; Lu Wang; Olusegun K Onibonoje; Chad Parrett; Daniel I Sessler; Loran Mounir-Soliman; Sherif Zaky; Viktor Krebs; Leonard T Buller; Michael C Donohue; Jennifer E Stevens-Lapsley; Brian M Ilfeld Journal: Anesthesiology Date: 2012-03 Impact factor: 7.892
Authors: Bahareh Khatibi; Engy T Said; Jacklynn F Sztain; Amanda M Monahan; Rodney A Gabriel; Timothy J Furnish; Johnathan T Tran; Michael C Donohue; Brian M Ilfeld Journal: Anesth Analg Date: 2017-04 Impact factor: 5.108
Authors: S J Madison; A M Monahan; R R Agarwal; T J Furnish; E J Mascha; Z Xu; M C Donohue; A C Morgan; B M Ilfeld Journal: Br J Anaesth Date: 2014-09-23 Impact factor: 9.166
Authors: Brian M Ilfeld; Vanessa J Loland; NavParkash S Sandhu; Preetham J Suresh; Michael J Bishop; Michael C Donohue; Eliza J Ferguson; Sarah J Madison Journal: Anesth Analg Date: 2012-06-28 Impact factor: 5.108
Authors: Michael Rasmussen; Eugenia Kim; T Edward Kim; Steven K Howard; Seshadri Mudumbai; Nicholas J Giori; Steven Woolson; Toni Ganaway; Edward R Mariano Journal: J Anesth Date: 2014-09-13 Impact factor: 2.078